Tata Motors CV shares trade at 6% discount to Ashok Leyland; worth a buy?

Tata Motors CV: Ambit Capital expects 6 per cent and 8 per cent CAGR in revenue and Ebitda between FY25 and FY28, supported ...
The Manila Times

Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS

Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target effects associated with meaningful clinical outcomes, including hemogl ...